|
|
||||||||
2 Dosage Is Critical for B Cell Development in the Absence of Adaptor Protein BLNK1


* Laboratory of Immunology, Center for Molecular Medicine and Institute of Molecular and Cell Biology, Singapore; and
Laboratory of Lymphocyte Differentiation, RIKEN Research Center for Allergy and Immunology, Yokohama, Japan
B cell linker (BLNK) protein and phospholipase C
2 (PLC
2) are components of the BCR signalosome that activate calcium signaling in B cells. Mice lacking either molecule have a severe but incomplete block in B lymphopoiesis. In this study, we generated BLNK/PLC
2/ mice to examine the effect of simultaneous disruption of both molecules on B cell development. We showed that BLNK/PLC
2/ mice had compounded defects in B cell maturation compared with either single mutant, suggesting that these two molecules cooperatively or synergistically signaled B lymphopoiesis. However, Ig H chain allelic exclusion was maintained in single and double mutants, indicating that signals propagated by BLNK and PLC
2 were not involved in this process. Interestingly, in the absence of BLNK, B cell development was dependent on plc
2 gene dosage. This was evidenced by the proportionate decrease in splenic B cell population and increase in bone marrow surface pre-BCR+ cells in PLC
2-diploid, -haploid, and -null animals. Intracellular calcium signaling and ERK activation in response to BCR engagement were also proportionately decreased and delayed, respectively, with stepwise reduction of plc
2 dosage in a BLNKnull background. Thus, these data indicate the importance of BLNK not only as a conduit to specifically channel BCR-signaling pathways and as a scaffold for the assembling of macromolecular complex, but also as an efficient aggregator or concentrator of PLC
2 molecules to effect optimal signaling for B cell generation and activation.
This article has been cited by other articles:
![]() |
Y. Imamura, A. Oda, T. Katahira, K. Bundo, K. A. Pike, M. J. H. Ratcliffe, and D. Kitamura BLNK Binds Active H-Ras to Promote B Cell Receptor-mediated Capping and ERK Activation J. Biol. Chem., April 10, 2009; 284(15): 9804 - 9813. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Oda, T. Ono, M. Yamamoto, R. Goitsuka, and D. Kitamura PKC{eta} directs induction of IRF-4 expression and Ig {kappa} gene rearrangement in pre-BCR signaling pathway Int. Immunol., November 1, 2008; 20(11): 1417 - 1426. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Xu, K.-G. Lee, J. Huo, T. Kurosaki, and K.-P. Lam Combined deficiencies in Bruton tyrosine kinase and phospholipase C{gamma}2 arrest B-cell development at a pre-BCR+ stage Blood, April 15, 2007; 109(8): 3377 - 3384. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |